BCM
ARRY

Beryl Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Beryl Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-73,531
Closed -$3.41M – 38
2019
Q2 		$3.41M Buy
+73,531
New +$2.06M 0.64% 8

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Beryl Capital Management's ARRY Position: Q3 2019 in Review

Beryl Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 73,531 shares — an estimated $3.41M sold.

Beryl Capital Management first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $3.41M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Beryl Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Beryl Capital Management sold 73,531 Array Biopharma Inc shares in Q3 2019, an estimated $3.41M.
  • Beryl Capital Management first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Beryl Capital Management's Array Biopharma Inc position peaked at $3.41M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Beryl Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.